Skip to main content
. Author manuscript; available in PMC: 2020 Oct 2.
Published in final edited form as: ACS Chem Neurosci. 2020 Apr 22;11(9):1300–1310. doi: 10.1021/acschemneuro.0c00064

Table 1.

Group Mean ED50 Values (95% CL) in Micrograms Per Kilogram and Fold Shift Relative to Baseline for Thermal Antinociception of Methadone, Heroin, Fentanyl, and a 1:27 Fentanyl/Heroin Mixture in Male and Female Rats of Cohort 1 (n = 3 Male, 3 Female)a

Methadone Heroin Fentanyl 1:27 Fentanyl/Heroin
Condition µg/kg ED50 (95% CL) Fold Change Condition µg/kg ED50 (95% CL) Fold Change Condition µg/kg ED50 (95% CL) Fold Change Condition *µg/kg ED50 (95% CL) Fold Change
Baseline 896 (431–1320) Baseline 129 (67–177)) Baseline 3.7 (2.0–5.2) Baseline 2.7 (1.2–4.0)
Naltrexone (0.032 mg/kg/h) >11687 (4981–18708) >13 Naltrexone (0.032 mg/kg/h) 2665 (1722–3536) 25.6 Naltrexone (0.032 mg/kg/h) 81.3 (41–124) 20.5 Naltrexone(0.032 mg/kg/h) 42.1 (29–56) 25.7
Day 1 487 (225–705) 0.6 Day 5 104 (60–138) 1.0 Day 7 11.3 (5.0–17) 3.4 Day 12 3.6 (2.5–4.7) 1.8
Day 14 775 (399–1103) 1.0 Day19 149 (95–192) 1.4 Day 21 39.6 (23–55) 13.5 Day 26 6.8 (4.2–9.1) 3.4
Day 28 1738 (800–2360) 2.7 Day 33 159 (100–205) 1.5 Day 35 37.9 (16–59) 11.9 Day 40 7.2 (3.4–10.3) 3.3
Day 42 837 (325–1243) 1.7 Day 47 142 (106–176) 1.4 Day 49 52.9 (44–62) 19.7 Day 54 14.9 (7.4–20) 7.5
Day 56 611 (317–888) 0.7 Day 61 200 (116–271) 1.8 Day 63 72.4 (30–104) 19.1 Day 68 10.3 (7.2–13) 4.9
Day 70 1117 (597–1601) 1.6 Day 75 269 (168–357) 2.5 Day 77 63.9 (38–86) 20.2 Day 82 12.8 (4.9–18) 5.1
Day 84 959 (632–1257) 1.3 Day 89 461 (214–670) 4.6 Day 91 85.1 (41–119) 27.1 Day 96 6.3 (2.7–9.1) 2.4
Day 98 974 (502–1404) 1.3 Day 103 329 (158–492) 2.9 Day 105 42.0 (20–63) 11.4 *ED50 reflects fentanyl dose
a

Bolded and underlined conditions indicate that 95% confidence limits of ED50 values did not overlap with those of baseline conditions for a given opioid.

b

ED50 reflects fentanyl dose